These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31469921)

  • 1. Longitudinal reliability of outcome measures in patients with Duchenne muscular dystrophy.
    Nagy S; Schädelin S; Hafner P; Bonati U; Scherrer D; Ebi S; Schmidt S; Orsini AL; Bieri O; Fischer D
    Muscle Nerve; 2020 Jan; 61(1):63-68. PubMed ID: 31469921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 6-minute walk test, motor function measure and quantitative thigh muscle MRI in Becker muscular dystrophy: A cross-sectional study.
    Fischer D; Hafner P; Rubino D; Schmid M; Neuhaus C; Jung H; Bieri O; Haas T; Gloor M; Fischmann A; Bonati U
    Neuromuscul Disord; 2016 Jul; 26(7):414-22. PubMed ID: 27209345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative muscle MRI: A powerful surrogate outcome measure in Duchenne muscular dystrophy.
    Bonati U; Hafner P; Schädelin S; Schmid M; Naduvilekoot Devasia A; Schroeder J; Zuesli S; Pohlman U; Neuhaus C; Klein A; Sinnreich M; Haas T; Gloor M; Bieri O; Fischmann A; Fischer D
    Neuromuscul Disord; 2015 Sep; 25(9):679-85. PubMed ID: 26096788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: A cross-sectional analysis.
    Schmidt S; Hafner P; Klein A; Rubino-Nacht D; Gocheva V; Schroeder J; Naduvilekoot Devasia A; Zuesli S; Bernert G; Laugel V; Bloetzer C; Steinlin M; Capone A; Gloor M; Tobler P; Haas T; Bieri O; Zumbrunn T; Fischer D; Bonati U
    Neuromuscul Disord; 2018 Jan; 28(1):16-23. PubMed ID: 29174526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.
    Mankodi A; Bishop CA; Auh S; Newbould RD; Fischbeck KH; Janiczek RL
    Neuromuscul Disord; 2016 Oct; 26(10):650-658. PubMed ID: 27593185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials.
    Ricotti V; Evans MR; Sinclair CD; Butler JW; Ridout DA; Hogrel JY; Emira A; Morrow JM; Reilly MM; Hanna MG; Janiczek RL; Matthews PM; Yousry TA; Muntoni F; Thornton JS
    PLoS One; 2016; 11(9):e0162542. PubMed ID: 27649492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T2 Mapping and Fat Quantification of Thigh Muscles in Children with Duchenne Muscular Dystrophy.
    Yin L; Xie ZY; Xu HY; Zheng SS; Wang ZX; Xiao JX; Yuan Y
    Curr Med Sci; 2019 Feb; 39(1):138-145. PubMed ID: 30868504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.
    Hafner P; Bonati U; Rubino D; Gocheva V; Zumbrunn T; Gueven N; Fischer D
    Trials; 2016 Aug; 17(1):389. PubMed ID: 27488051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort.
    Forbes SC; Arora H; Willcocks RJ; Triplett WT; Rooney WD; Barnard AM; Alabasi U; Wang DJ; Lott DJ; Senesac CR; Harrington AT; Finanger EL; Tennekoon GI; Brandsema J; Daniels MJ; Sweeney HL; Walter GA; Vandenborne K
    Radiology; 2020 Jun; 295(3):616-625. PubMed ID: 32286193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial.
    Nagy S; Hafner P; Schmidt S; Rubino-Nacht D; Schädelin S; Bieri O; Fischer D
    Trials; 2019 Nov; 20(1):637. PubMed ID: 31752977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy.
    Nagy S; Schmidt S; Hafner P; Klein A; Rubino-Nacht D; Gocheva V; Bieri O; Vuillerot C; Bonati U; Fischer D
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30688316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI Assessment of Motor Capabilities in Patients with Duchenne Muscular Dystrophy According to the Motor Function Measure Scale.
    Suslov V; Suslova G; Lytaev S
    Tomography; 2022 Apr; 8(2):948-960. PubMed ID: 35448710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy.
    Barnard AM; Willcocks RJ; Finanger EL; Daniels MJ; Triplett WT; Rooney WD; Lott DJ; Forbes SC; Wang DJ; Senesac CR; Harrington AT; Finkel RS; Russman BS; Byrne BJ; Tennekoon GI; Walter GA; Sweeney HL; Vandenborne K
    PLoS One; 2018; 13(3):e0194283. PubMed ID: 29554116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience.
    Gaeta M; Messina S; Mileto A; Vita GL; Ascenti G; Vinci S; Bottari A; Vita G; Settineri N; Bruschetta D; Racchiusa S; Minutoli F
    Skeletal Radiol; 2012 Aug; 41(8):955-61. PubMed ID: 22069033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal study of multi-parameter quantitative magnetic resonance imaging in Duchenne muscular dystrophy: hyperresponsiveness of gluteus maximus and detection of subclinical disease progression in functionally stable patients.
    Peng F; Xu H; Song Y; Xu K; Li S; Cai X; Guo Y; Gong L
    J Neurol; 2023 Mar; 270(3):1439-1451. PubMed ID: 36385201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory Duchenne muscular dystrophy children: cross-sectional correlation between function, quantitative muscle ultrasound and MRI.
    Abdulhady H; Sakr HM; Elsayed NS; El-Sobky TA; Fahmy N; Saadawy AM; Elsedfy H
    Acta Myol; 2022 Mar; 41(1):1-14. PubMed ID: 35465338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal 2-point dixon muscle magnetic resonance imaging in becker muscular dystrophy.
    Bonati U; Schmid M; Hafner P; Haas T; Bieri O; Gloor M; Fischmann A; Fischer D
    Muscle Nerve; 2015 Jun; 51(6):918-21. PubMed ID: 25736228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle MRI: A biomarker of disease severity in Duchenne muscular dystrophy? A systematic review.
    Ropars J; Gravot F; Ben Salem D; Rousseau F; Brochard S; Pons C
    Neurology; 2020 Jan; 94(3):117-133. PubMed ID: 31892637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of the T2 relaxation time of the gluteus muscles in children with Duchenne muscular dystrophy: a comparative study before and after steroid treatment.
    Kim HK; Laor T; Horn PS; Wong B
    Korean J Radiol; 2010; 11(3):304-11. PubMed ID: 20461184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserved thenar muscles in non-ambulant Duchenne muscular dystrophy patients.
    Naarding KJ; Keene KR; Sardjoe Mishre ASD; Veeger TTJ; van de Velde NM; Prins AJ; Burakiewicz J; Verschuuren JJGM; van der Holst M; Niks EH; Kan HE
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):694-703. PubMed ID: 33963807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.